Archive for 2013

Association for Molecular Pathology v Myriad: Attorneys React

This guest post is from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. While the dust has settled on the oral hearings of Association for Molecular Pathology (AMP) v Myriad (read our report […]


Biotechblog